DCGI gives final approval for Covid-19 vaccines of SII, Bharat Biotech
The Drugs Controller General of India (DCGI) has formally announced the final approval for Oxford-AstraZeneca "Covishield" and Bharat Biotech 'Covaxin' vaccines against the coronavirus disease (Covid-19) for emergency use. CDSCO (Central Drugs Standard Control Organisation) accepts the subject expert committee reform rations on Serum and Bharat Biotech Covid vaccines.
About Covishield:
The subject expert committee (SEC) under CDSCO had recommended Oxford-AstraZeneca‘s vaccine, which is being manufactured by the Serum Institute of India (SII) as Covishield, for emergency use and Covaxin for restricted use. About Covaxin: Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
India to chair 3 key subsidiary bodies of UN Security Council
The Permanent Representative of India to the UN, T S
Tirumurti has announced that India has been asked to
chair three important committees of the UN Security
Council (UNSC), during its tenure as a non-permanent
member of the powerful 15-nation UN body.
The three highly significant committees include:
1. Taliban Sanctions Committee
2. Counter-Terrorism Committee
3. Libyan Sanctions Committee
Among these, India will chair the Counter-Terrorism
Committee of UNSC in 2022, which coincides with the
75th anniversary of India's independence. India began its
two-year term at UNSC from January 01, 2021. It is the
eighth time that the country has joined UNSC as the non-permanent member. In 2021, along with India, Norway,
Kenya, Ireland and Mexico joined as non-permanent
members in the Council.